| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Clover Health Investments (NASDAQ:CLOV) reported quarterly losses of $(0.05) per share which missed the analyst consensus estim...
Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Fr...
Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company") today annou...
Chamath Palihapitiya is back with another SPAC. This time he's telling retail investors to stay away. Here's why.
Chamath Palihapitiya is back with a new SPAC. Many investors will remember past SPACs the investor was involved with and the po...